AlphaFold predicted structure
RTN2 · O75298

Mean pLDDT
51.2/ 100
Low
545 residues
Confidence breakdown
- Very high(≥ 90)0%
- Confident(70–90)15%
- Low(50–70)28%
- Very low(< 50)58%
AlphaFold (Jumper et al., 2021) · CC BY 4.0
reticulon 2
Annotations refreshed 9 hours ago.
Diagnostic Grade (Green)
Adult onset hereditary spastic paraplegia
MONOALLELIC, autosomal or pseudoautosomal, imprinted status unknownChildhood onset hereditary spastic paraplegia
BOTH monoallelic and biallelic, autosomal or pseudoautosomalHereditary neuropathy or pain disorder
BIALLELIC, autosomal or pseudoautosomalHereditary spastic paraplegia
BOTH monoallelic and biallelic, autosomal or pseudoautosomalAdult onset neurodegenerative disorder
MONOALLELIC, autosomal or pseudoautosomal, imprinted status unknownIntellectual disability
MONOALLELIC, autosomal or pseudoautosomal, imprinted status unknownhereditary spastic paraplegia 12
Autosomal dominant spastic paraplegia type 12
neuronopathy, distal hereditary motor, autosomal recessive 11, with spasticity
Spastic paraplegia
distal hereditary motor neuropathy
Lower limb spasticity
hereditary disease
hereditary spastic paraplegia
gastric cancer
gastric ulcer
Score is the Open Targets composite evidence score (0-1). Higher = stronger gene-disease association.
Reticulon-2
Inhibits amyloid precursor protein processing, probably by blocking BACE1 activity (PubMed:15286784). Enhances trafficking of the glutamate transporter SLC1A1/EAAC1 from the endoplasmic reticulum to the cell surface (By similarity). Plays a role in the translocation of SLC2A4/GLUT4 from intracellular membranes to the cell membrane which facilitates the uptake of glucose into the cell (By similarity)
RTN2 · O75298

Mean pLDDT
51.2/ 100
Low
545 residues
Confidence breakdown
AlphaFold (Jumper et al., 2021) · CC BY 4.0